Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients

Pediatric Dermatology

Volumn 28, Issue 4, 2011, Pages 393-396

  Hong, Esther ^a   Smith, Saxon ^b   Fischer, Gayle ^a,c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CORTICOSTEROID; HYDROCORTISONE ACETATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE;

ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMAL ATROPHY AND TELANGIECTASIA SCALE; DERMATITIS; DRUG SAFETY; ECZEMA; ECZEMA AREA AND SEVERITY INDEX; EPILUMINESCENCE MICROSCOPY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS; RATING SCALE; SCORING SYSTEM; SKIN ATROPHY; TELANGIECTASIA; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; ECZEMA; FEMALE; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; SKIN; TELANGIECTASIS; TREATMENT OUTCOME;

EID: 79960846055     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01445.x     Document Type: Article

References (16)

1. Eichenfield L, Fowler J, Rigel D, et al., Natural advances in eczema care. Cutis 2007; 80: S2-S16.
2. Charman C, Morris A, Williams H,. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931-936. (Pubitemid 30304603)
3. Fischer G,. Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996; 37: S10-S13. (Pubitemid 126443314)
4. Skoner J, Schaffner T, Schad C, et al., Addressing steroid phobia: improving the risk-benefit ration with new agents. Allergy Asthma Proc 2008; 29: 358-364.
5. Brown K, Rehmus W, Kimball A,. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006; 55: 607-613. (Pubitemid 44436629)
6. Smith S, Hong E, Fearns S, et al., Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol 2010; 51: 168-174.
7. Cork M, Britton J, Butler L, et al., Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-589. (Pubitemid 37281592)
8. Ben-Gashir M, Seed P, Hay R,. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004; 150: 284-290. (Pubitemid 38352466)
9. Chamlin S,. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther 2006; 19: 104-107.
10. Frosch P, Behrenbeck E, Frosch K, et al., The Duhring chamber assay for corticosteroid atrophy. Br J Dermatol 1981; 104: 57-65. (Pubitemid 11051225)
11. Murrell D, Calvieri S, Ortonne J, et al., A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on topical corticosteroids. Br J Dermatol 2007; 157: 954-959. (Pubitemid 47583533)
12. Vazquez-Lopez F, Marghoob A,. Dermoscopic assessment of long-term topical therapies with potent steroids in chronic psoriasis. J Am Acad Dermatol 2004; 51: 811-813. (Pubitemid 39516902)
13. Hanifin J, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Vernereol Suppl (Stockh) 1980; 92: 44-47.
14. Morris A, Rogers M, Fischer G, et al., Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18: 188-198. (Pubitemid 32567869)
15. Gilbertson E, Spellman M, Piacquadio D, et al., Super potent corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998; 38: 318-321. (Pubitemid 28115240)
16. Chisolm S, Taylor S, Balkrishnan R, et al., Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 2008; 59: 677-683.